Takeda Pharmaceutical Limited (TAK) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Takeda Pharmaceutical Li...

    NYSE: TAK · Real-Time Price · USD
    15.28
    0.01 (0.07%)
    At close: Sep 09, 2025, 3:30 PM

    Takeda Pharmaceutical Balance Sheet Statement

    Financials in JPY. Fiscal year is April - March.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Mar 31, 2025 Mar 31, 2024 Mar 31, 2023 Mar 31, 2022
    Cash & Equivalents
    		 385.11B 457.8B 533.53B 849.7B
    Short-Term Investments
    		 20.48B 15.09B 20.17B 25.3B
    Long-Term Investments
    		 10.8B 430.61B 378.86B 330.13B
    Other Long-Term Assets
    		 792.15B 51.21B 63.33B 82.61B
    Receivables
    		 725.25B 697.61B 681.69B 724.38B
    Inventory
    		 1,217.3B 1,209.9B 986.46B 853.17B
    Other Current Assets
    		 209.26B 193.3B 302.54B 273.26B
    Total Current Assets
    		 2,521.2B 2,558.6B 2,398B 2,593.6B
    Property-Plant & Equipment
    		 1,968.2B 1,989.8B 1,691.2B 1,582.8B
    Goodwill & Intangibles
    		 8,956B 9,684.7B 9,060.4B 8,226.3B
    Total Long-Term Assets
    		 11,727.2B 12,550.2B 11,559.8B 10,584.4B
    Total Assets
    		 14,248.3B 15,108.8B 13,957.8B 13,178B
    Account Payables
    		 475.54B 319.95B 307.45B 295.93B
    Deferred Revenue
    		 n/a n/a 740.74B 644.42B
    Short-Term Debt
    		 548.94B 367.25B 339.6B 203.99B
    Other Current Liabilities
    		 1,482B 1,516B 1,775.3B 1,591.9B
    Total Current Liabilities
    		 2,506.5B 2,313.1B 2,481.9B 2,145.7B
    Long-Term Debt
    		 3,966.3B 4,476.5B 4,042.7B 4,141.4B
    Other Long-Term Liabilities
    		 288.62B 377.98B 179.93B 124.8B
    Total Long-Term Liabilities
    		 4,805.8B 5,521.7B 5,121.1B 5,348.8B
    Total Liabilities
    		 7,312.4B 7,834.8B 7,603.1B 7,494.5B
    Total Debt
    		 5,066.2B 4,843.8B 4,382.3B 4,345.4B
    Common Stock
    		 1,694.7B 1,676.6B 1,676.3B 1,676.3B
    Retained Earnings
    		 1,187.6B 1,391.2B 1,541.1B 1,479.7B
    Comprehensive Income
    		 2,351.9B 2,509.3B 1,508.1B 934.17B
    Shareholders Equity
    		 6,935.1B 7,273.3B 6,354.1B 5,683B
    Total Investments
    		 10.8B 445.7B 99.17B 96.58B

    Add to Watchlist